Clene- Warrants (30/12/2025) EBIT

As of the most recent data (June 2026), CLNNW shows a EBIT of $-21M. That compares with $-32M in the prior-year period — up 32.1% year over year. That is below the Healthcare sector average of $22B. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, CLNNW's EBIT is now $-21M (was $-32M) — a 32.1% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Clene- Warrants (30/12/2025) is outperforming or lagging.

The Healthcare sector average EBIT is about $22B. Clene- Warrants (30/12/2025) is at $-21M, which is lower that average. That is roughly 100.1% below the sector mean. Use the comparison chart on this page to see how CLNNW stacks up against individual peers as well.

Tracking CLNNW's ebit over time shows whether Clene- Warrants (30/12/2025) is scaling, shrinking, or reshaping that part of the business. The current reading is $-21M That compares with $-32M in the prior-year period — up 32.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this ebit page, Stockcircle has Clene- Warrants (30/12/2025)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect EBIT (currently $-21M) with ownership activity and broader fundamentals.